Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Autonomix Medical, Inc. (AMIX : NSDQ)

• Company Description    Autonomix Medical Inc. is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. Autonomix Medical Inc. is based in THE WOODLANDS, TX. Number of Employees: 8

• Price / Volume Information    Yesterday's Closing Price: $4.39 Daily Weekly Monthly 20 Day Moving Average: 2,413,291 shares Shares Outstanding: 0.97 (millions) Market Capitalization: $4.26 (millions) Beta: -1.00 52 Week High: $32.55 52 Week Low: $2.44 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -36.08% -34.33% 12 Week -42.69% -43.38% Year To Date -62.05% -65.78%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 21 WATERWAY AVENUE SUITE 300 - THE WOODLANDS,TX 77380 USA ph: 713-588-6150 fax: - autonomix@jtcir.com http://www.autonomix.com

• General Corporate Information    Officers Brad Hauser - Chief Executive Officer; President and Director Walter Klemp - Executive Chair of the Board of Directors LORI BISSON - Vice Chair of the Board of Directors Trent Smith - Chief Financial Officer Jonathan Foster - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 05330T304 SIC: 3841 Fiscal Year Fiscal Year End: March Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/11/26 Share - Related Items Shares Outstanding: 0.97 Most Recent Split Date: 6.00 (0.05:1) Beta: -1.00 Market Capitalization: $4.26 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-20.17 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.35 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 77.67% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/26 - -267.73 03/31/26 - -239.36 12/31/25 - -228.82 ROA 06/30/26 - -216.75 03/31/26 - -192.46 12/31/25 - -186.65 Current Ratio 06/30/26 - 4.85 03/31/26 - 4.45 12/31/25 - 6.18 Quick Ratio 06/30/26 - 4.85 03/31/26 - 4.45 12/31/25 - 6.18 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Book Value 06/30/26 - 3.26 03/31/26 - 10.85 12/31/25 - 26.04 Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - 0.00 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - 0.00 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©